Respiri Ltd (RSH) - Financial and Strategic SWOT Analysis Review

November 2021 | 49 pages | ID: R5ABAE490A8EN
GlobalData

Abstracts

Respiri Ltd (RSH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Respiri Ltd (Respiri), formerly iSonea Ltd, is a medical technology company that conducts research, development, and commercialization of medical devices and mobile health applications to improve the management of chronic respiratory disorders such as asthma. The company’s proprietary applications, software, and devices will help people monitor the symptoms of their conditions and increase their awareness of the risk of attack. Respiri’s proprietary technology, Acoustic Respiratory Monitoring (ARM) records airway sounds and detects breath sounds and helps in measuring the extent of wheezing caused by airway obstruction. It offers wheezo, an asthma management tool that helps patients in the management of their health condition. The company has operations in Australia and Israel. Respiri is headquartered in Melbourne, Victoria, Australia.

Respiri Ltd Key Recent Developments

Jun 07,2021: Adherium responds to Respiri announcement
Apr 29,2021: Respiri: March 2021 quarterly cash flow and quarterly activities report
Mar 25,2021: Respiri : Strategic advisor appointments and UK update
Jan 27,2021: Respiri : December 2020 quarterly cash flow and quarterly activities report
Oct 22,2020: Respiri : September 2020 appendix 4C quarterly cash flow and quarterly activities report

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

SECTION 1 - ABOUT THE COMPANY

Respiri Ltd - Key Facts
Respiri Ltd - Key Employees
Respiri Ltd - Key Employee Biographies
Respiri Ltd - Major Products and Services
Respiri Ltd - History
Respiri Ltd - Company Statement
Respiri Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
Respiri Ltd - Business Description
Geographical Segment: Australia
Performance
Overview
Geographical Segment: Israel
Performance
Overview
Respiri Ltd - Corporate Strategy
Respiri Ltd - SWOT Analysis
SWOT Analysis - Overview
Respiri Ltd - Strengths
Respiri Ltd - Weaknesses
Respiri Ltd - Opportunities
Respiri Ltd - Threats
Respiri Ltd - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Respiri Ltd, Medical Equipment, Deals By Year, 2015 to YTD 2021
Respiri Ltd, Medical Equipment, Deals By Type, 2015 to YTD 2021
Respiri Ltd, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Jun 07, 2021: Adherium responds to Respiri announcement
Apr 29, 2021: Respiri: March 2021 quarterly cash flow and quarterly activities report
Mar 25, 2021: Respiri : Strategic advisor appointments and UK update
Jan 27, 2021: Respiri : December 2020 quarterly cash flow and quarterly activities report
Oct 22, 2020: Respiri : September 2020 appendix 4C quarterly cash flow and quarterly activities report
Jul 27, 2020: Respiri provides CY21 revenue guidance of $6-$8 million
Apr 29, 2020: Respiri : March 2020 cash flow and quarterly activities report

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Respiri Ltd, Key Facts
Respiri Ltd, Key Employees
Respiri Ltd, Key Employee Biographies
Respiri Ltd, Major Products and Services
Respiri Ltd, History
Respiri Ltd, Subsidiaries
Respiri Ltd, Key Competitors
Respiri Ltd, Ratios based on current share price
Respiri Ltd, Annual Ratios
Respiri Ltd, Annual Ratios (Cont...1)
Respiri Ltd, Annual Ratios (Cont...2)
Respiri Ltd, Interim Ratios
Respiri Ltd, Medical Equipment, Deals By Year, 2015 to YTD 2021
Respiri Ltd, Medical Equipment, Deals By Type, 2015 to YTD 2021
Respiri Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

Respiri Ltd, Performance Chart (2017 - 2021)
Respiri Ltd, Ratio Charts
Respiri Ltd, Medical Equipment, Deals By Year, 2015 to YTD 2021
Respiri Ltd, Medical Equipment, Deals by Type, 2015 to YTD 2021